Cell Source, Inc. Files 8-K Under 'Other Events'
Ticker: CLCS · Form: 8-K · Filed: Apr 9, 2024 · CIK: 1569340
| Field | Detail |
|---|---|
| Company | Cell Source, Inc. (CLCS) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $7.50, $4,760,170, $1.25 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, other-events, corporate-action
TL;DR
Cell Source (TTC) filed an 8-K for an event on 3/22, but details are scarce. Watch for more info.
AI Summary
Cell Source, Inc. (formerly Ticket to See, Inc.) filed an 8-K on April 9, 2024, reporting an event on March 22, 2024. The filing is categorized under 'Other Events' and does not provide specific details on the nature of the event or any associated financial figures.
Why It Matters
This filing indicates a material event has occurred for Cell Source, Inc., but the lack of detail requires further investigation to understand its implications.
Risk Assessment
Risk Level: medium — The filing is an 8-K under 'Other Events' with no specific details, creating uncertainty about the nature and impact of the reported event.
Key Players & Entities
- Cell Source, Inc. (company) — Registrant
- Ticket to See, Inc. (company) — Former name of Registrant
- 20240409 (date) — Filing Date
- 20240322 (date) — Date of Earliest Event Reported
FAQ
What specific event occurred on March 22, 2024, that necessitated this 8-K filing?
The filing is categorized under 'Other Events' and does not provide specific details regarding the event that occurred on March 22, 2024.
What is the significance of the 'Other Events' category for this filing?
The 'Other Events' category is used for significant events that do not fall under the other specific items of Form 8-K, suggesting a material development for the company.
Has Cell Source, Inc. provided any further information or amendments regarding this filing?
This filing is the initial 8-K report as of April 9, 2024; no subsequent amendments or additional details are mentioned within this document.
What was the previous name of Cell Source, Inc. and when did the name change occur?
The former name of Cell Source, Inc. was Ticket to See, Inc., and the date of the name change was February 11, 2013.
Where is Cell Source, Inc. incorporated and what is its principal executive office address?
Cell Source, Inc. is incorporated in Nevada and its principal executive offices are located at 57 West 57th Street, Suite 400, New York, New York 10019.
Filing Stats: 315 words · 1 min read · ~1 pages · Grade level 11.1 · Accepted 2024-04-09 12:05:30
Key Financial Figures
- $7.50 — referred Stock at a conversion price of $7.50 per share. The Company sold $4,760,170
- $4,760,170 — ce of $7.50 per share. The Company sold $4,760,170 aggregate principal amount of notes in
- $1.25 — of common stock at an exercise price of $1.25 per share. Additional subscriptions wil
Filing Documents
- form8-k.htm (8-K) — 28KB
- 0001493152-24-014035.txt ( ) — 189KB
- clcs-20240322.xsd (EX-101.SCH) — 3KB
- clcs-20240322_lab.xml (EX-101.LAB) — 33KB
- clcs-20240322_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 9, 2024 Cell Source, Inc. By: /s/ Itamar Shimrat Itamar Shimrat President and Chief Executive Officer